Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection

Given emerging evidence of immune escape in the SARS-CoV-2 Omicron viral variant, and its dominance, effectiveness of heterologous and homologous boosting schedules commonly used in low-to-middle income countries needs to be re-evaluated. We conducted a test-negative design using consolidated nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Suah, Jing Lian, Tng, Boon Hwa, Tok, Peter Seah Keng, Husin, Masliyana, Thevananthan, Thevesh, Peariasamy, Kalaiarasu M., Sivasampu, Sheamini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132393/
https://www.ncbi.nlm.nih.gov/pubmed/35499301
http://dx.doi.org/10.1080/22221751.2022.2072773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132393/
https://www.ncbi.nlm.nih.gov/pubmed/35499301
http://dx.doi.org/10.1080/22221751.2022.2072773

Ejemplares similares